Evidence map›Paper›PMID 23135632›Full record

ArticleMolecules (Basel, Switzerland)2012

Synthesis, antioxidant and antimicrobial activity of a new phloridzin derivative for dermo-cosmetic applications.

Anna Baldisserotto, Gemma Malisardi, Emanuela Scalambra, Elisa Andreotti, Carlo Romagnoli, Chiara Beatrice Vicentini, Stefano Manfredini, Silvia Vertuani

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. MethanolicNutrients · 2022
    Article
  11. Toxins · 2021
    Article
  12. Review
  13. Review
  14. Naturally Occurring SGLT2 Inhibitors: A Review.Advances in experimental medicine and biology · 2021
    Review
  15. Plants (Basel, Switzerland) · 2020
    Review
  16. Antioxidants as an Epidermal Stem Cell Activator.Antioxidants (Basel, Switzerland) · 2020
    Review
  17. Article
  18. Article
  19. Phytochemical Screening of Quaking Aspen (Molecules (Basel, Switzerland) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anna BaldisserottoDepartment of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy. bldnna@unife.it
Gemma Malisardi
Emanuela Scalambra
Elisa Andreotti
Carlo Romagnoli
Chiara Beatrice Vicentini
Stefano Manfredini
Silvia Vertuani
University of Ferrara · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phenolic compound phloridzin (phloretin 2′-O-glucoside, variously named phlorizin, phlorrhizin, phlorhizin or phlorizoside) is a prominent member of the chemical class of dihydrochalcones, which are phenylpropanoids. Phloridzin is specifically found in apple and apple juice and known for its biological properties. In particular we were attracted by potential dermo-cosmetic applications. Here we report the synthesis, stability studies and antimicrobial activity of compound F2, a new semi-synthetic derivative of phloridzin. The new derivative was also included in finished formulations to evaluate its stability with a view to a potential topical use. Stability studies were performed by HPLC; PCL assay and ORAC tests were used to determine the antioxidant activity. F2 presented an antioxidant activity very close to that of the parent phloridzin, but, unlike the latter, was more stable in formulations. To further explore potential health claims, antifungal activity of phloridzin and its derivative F2 were determined; the results, however, were rather low; the highest value was 31,6% of inhibition reached by F2 on Microsporum canis at the highest dose.

Indexed as

Antifungal AgentsAntioxidantsChemistry, PharmaceuticalCosmeticsDrug StabilityEthanolHydrogen-Ion ConcentrationHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsMicrosporumOctanolsPhlorhizinSolventsWaterAntifungal AgentsAntioxidantsCosmeticsEthanolOctanolsPhlorhizinSolventsWater

Identifiers

PMID23135632
PMCPMC6268407
OpenAlexW2020211540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.